aspirin and 14-hydroxydocosahexaenoate

aspirin has been researched along with 14-hydroxydocosahexaenoate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barden, AE; Croft, KD; Mas, E; Mori, TA; Phillips, M	1

Trials

1 trial(s) available for aspirin and 14-hydroxydocosahexaenoate

Article	Year
Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin. The American journal of clinical nutrition, 2015, Volume: 102, Issue:6 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Combined Modality Therapy; Cyclooxygenase Inhibitors; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Fish Oils; Humans; Immunity, Innate; Male; Metabolic Syndrome; Middle Aged; Postmenopause; Tablets, Enteric-Coated; Western Australia; Young Adult	2015

Article

Year

Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.

The American journal of clinical nutrition, 2015, Volume: 102, Issue:6

Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Combined Modality Therapy; Cyclooxygenase Inhibitors; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Fish Oils; Humans; Immunity, Innate; Male; Metabolic Syndrome; Middle Aged; Postmenopause; Tablets, Enteric-Coated; Western Australia; Young Adult

2015